IRD - Opus Genetics, Inc.
0.7085
-0.005 -0.748%
Share volume: 277,044
Last Updated: 04-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.14%
PREVIOUS CLOSE
CHG
CHG%
$0.71
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-10-2024 | 08-13-2024 | 11-12-2024 | |
| Total revenue | 1.711 M | 1.112 M | 3.867 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.711 M | 1.112 M | 3.867 M | |
| -35.01% | 247.75% | |||
| Operating expenses | 9.419 M | 9.440 M | 11.876 M | |
| Selling general and admin | 4.670 M | 3.354 M | 2.894 M | |
| Research and development | 4.749 M | 6.086 M | 8.982 M | |
| Total expenses | 9.419 M | 9.440 M | 11.876 M | |
| 0.22% | 25.81% | |||
| Operating income | -7.708 M | -8.328 M | -8.009 M | |
| Ebit | -7.106 M | -7.765 M | -7.526 M | |
| Pretax income | -7.106 M | -7.765 M | -7.526 M | |
| 9.27% | -3.08% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -7.106 M | -7.765 M | -7.526 M | |
| -9.27% | 3.08% |
